Bactiseal Catheter Safety Registry in China - Trial NCT04496414
Access comprehensive clinical trial information for NCT04496414 through Pure Global AI's free database. This phase not specified trial is sponsored by Integra LifeSciences Corporation and is currently Completed. The study focuses on Hydrocephalus. Target enrollment is 50 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Integra LifeSciences Corporation
Timeline & Enrollment
N/A
Sep 01, 2020
Nov 30, 2020
Primary Outcome
50 Participants With Non-infection Within One Year
Summary
Research Purpose: This study aimed to continue to evaluate safety information from subjects
 implanted with a catheter (trade name: Bactiseal) produced by Codman & Shurtleff, Inc. of the
 United States. Device safety would be assessed based on all the adverse events that occurred
 within one year after the subjects implanted the catheter.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT04496414
Device Trial